TEMPLATE

Leaders in Learning: Publications of Faculty & Staff

Medicine (Dept.): 1998-1999

ADAMS, P.C.

Adams, P.C. 1998. Hemochromatosis: clinical implications of genetic testing. Canadian Medical Association Journal 159: 156-158.

Adams, P.C. 1999. Population screening for hemochromatosis. Hepatology 29: 1324-1327.

Adams, P.C., and L.S. Valberg. 1999. Screening blood donors for hereditary hemochromatosis: Decision analysis model comparing genotyping to phenotyping. American Journal of Gastroenterology 94: 1593-1600.

Bacon, B., L. Powell, P.C. Adams, T. Kresina, and J. Hoofnagle. 1999. Molecular medicine and hemochromatosis: At the crossroads. Gastroenterology 116: 193-207.

Barton, J.C., S. McDonell, P.C. Adams, P. Brissot, L.W. Powell, C.Q. Edwards, J.D. Cook, and K. Kowdley. 1998. Management of hereditary hemochromatosis: Recommendations of a CDC management working group. Annals of Internal Medicine 129: 925-931.

Guyader, D., R. Moirand, C. Jacquelinet, B. Turlin, M. Mendler, J. Chaperon, V. David, P. Brissot, P.C. Adams, and Y. Deugnier. 1998. Non-invasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 115: 929-936.

Jeffrey, G.P., S. Chakrabarti, R.A. Hegele, and P.C. Adams . 1999. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nature Genetics 22: 325-326.

Jeffrey, G., K. Basclain, J. Hajek, S. Chakrabarti, and P.C. Adams. 1999. Alternate splicing produces a soluble form of the hereditary hemochromatosis protein HFE. Blood Cells, Molecules and Diseases 28: 61-67.

Kumar, N., W.J. Wall, D. Grant, M. Bloch, C.N. Ghent, P.C. Adams, and P.J. Marotta. 1999. Liver retransplantation. Transplantation Proceedings 31: 541-542.

McDonell, S., A. Grindon, B. Preston, J. Barton, C. Edwards, and P.C. Adams. 1999. A survey of phlebotomy among persons with hemochromatosis. Transfusion 39: 651-656.

McDonell, S., B. Preston, S. Jewell, J. Barton, C. Edwards, P.C. Adams, and R. Yip. 1999. A survey of 2,851 patients with hemochromatosis: Symptoms and response to treatment. American Journal of Medicine 106: 619-625.

AHMAD, D.

Sharpe, M.D., and D. Ahmad. 1999. Lung Transplantation. Bone's Atlas of Pulmonary and Critical Care Medicine. R.C. Bone, G.D.Jr. Campbell, and D.K. Payne. Philadelphia: Williams & Wilkins. 26-29.

ALMOND, D.G.

Dzavik, V., R.G. Carere, K. Teo Koon, M.L. Knudtson, J.F. Marquis, C.E. Buller, The Total Occlusion Study of Canada (TOSCA) Investigators, and D.G. Almond. 1998. An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a Heparin-coated stent, of totally occluded coronary. Canadian Journal of Cardiology 14: 825-832.

ARANY, E.

Hill, D.J., J. Hogg, J. Petrik, E. Arany, and V.K.M. Han. 1999. Cellular distribution and ontogeny of insulin-like growth factors (IGFs) and IGF binding protein messenger RNAs and peptides in developing rat pancreas. Journal of Endocrinology 160: 305-317.

Hill, D.J., J. Petrik, E. Arany, T.J. McDonald, and T.L. Delovitch. 1999. Insulin-like growth factors prevent cytokinemediated cell death in isolated islets of Langerhans from pre-diabetic NOD mice. Journal of Endocrinology 161: 153-165.

Petrik, J., J.M. Pell, E. Arany, T.J. McDonald, W.L. Dean, W. Reik, and D.J. Hill. 1999. Over-expression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 140: 2353-2363.

ARNOLD, J.M.O.

Arnold, J.M.O. 1998. The contemporary role of digoxin in heart failure. Perspectives in Cardiology 14: 39-48.

Arnold, J.M.O. 1999. Heart failure & ACE inhibitors (Preface). ACE Inhibitors in Clinical Practice. B. Shurlock. Winchester, England: Euromed.

Feng, Q.-P., A.J. Fortin, X.R. Lu, and J.M.O. Arnold. 1999. Effects of L-arginine on endothelial and cardiac function in rats with congestive heart failure. European Journal of Pharmacology 376: 37-44.

Gupta, A., and J.M.O. Arnold. 1998. Diagnosis of heart failure. Canadian Journal of Diagnosis 15: 95-107.

Humphreys, R.A., J.V. Haist, S. Chakrabart, Q.-P. Feng, J.M.O. Arnold, and M. Karmazyn. 1999. Orally administered NHE-1 inhibitor cariporide reduces acute response to coronary occlusion and reperfusion. American Journal Physiology 276: H749-H757.

Lambert, M.L., I.D. Callow, Q.-P. Feng, and J.M.O. Arnold. 1999. The effects of age on human venous responsiveness in neuropeptide Y. British Journal of Clinical Pharmacology 47: 83-89.

BAILEY, D.G.

Hall, S.D., K.E. Thummel, P.B. Watkins, K.S. Lown, L.Z. Benet, M.F. Paine, R.R. Mayo, D.K. Turgeon, D.G. Bailey, R.J. Fontana, and S.A. Wrighton. 1999. Molecular and physical mechanisms of first-pass extraction. Drug Metabolism and Disposition 27: 161-166.

BELL, D.

Ethiopia, A., and D. Bell. 1999. Gastric carcinoma in association with remitting seronegative symmetrical synovitis with pitting edema. Journal of Rheumatology 26: 5.

Joneja, M., and D. Bell. 1999. Arthritis in the elderly: Recognition and management. Canadian Journal of Continuing Medical Education (Feb.): 181-187.

BLAKE, P.G.

Blake, P.G. 1999. Adequacy, nutrition, and clinical outcomes. Peritoneal Dialysis International 19 (Suppl 2): S16-S19.

Blake, P.G. 1999. Advantages and disadvantages of automated peritoneal dialysis compared to continuous ambulatory peritoneal dialysis. Peritoneal Dialysis International 19 (Suppl 2): S121-S124.

Blake, P.G. 1998. The good news about peritoneal dialysis. Contemporary Dialysis & Nephrology 19 (2): 23-25.

Blake, P.G. 1999. Individualized prescription of peritoneal dialysis therapy? Peritoneal Dialysis International 19 (Suppl 2): S495-S498.

Blake, P.G. 1999. Practical guide to measuring adequacy of dialysis. Adv Ren Replace Ther 6 (1): 80-84.

Blake, P.G. 1999. Survival differences between peritoneal and hemodialysis: can conflicting results be explained? PD Today 5 (1): 18.

Blake, P.G., J.M. Bargman, J. Bick, P. Cartier, M.K. Dasgupta, A. Fine, S.D. Lavoie, E. Spanner, and P.A. Taylor. 1999. Guidelines for Adequacy and Nutrition in Peritoneal Dialysis. Journal of the American Society of Nephrology 10: S2897-S3321.

Blake, P.G., W.E. Bloembergen, and S.S. Fenton. 1998. Changes in the demographics and prescription of peritoneal dialysis during the last decade. American Journal of Kidney Diseases 32 (Suppl 4): S44-S51.

Churchill, D.N., P.G. Blake, K.K. Jindal, E.B. Toffelmire, and M.B. Goldstein. 1999. Clinical practice guidelines for initiation of dialysis. Journal of the American Society of Nephrology 10 (Suppl 13): S289-S291.

Lindsay, R.M., P.G. Blake, and E. Bradfield. 1998. The estimation of hemodialysis access blood flow rates by a urea methodology is a poor predictor of access outcome. ASAIO Journal 44: 818-822.

Mendelssohn, D.C., and P.G. Blake. 1999. Shifting sand: dialysis funding and modality distribution in Ontario. Nephrology News Issues 13 (3): 31-32, 37.

Mendelssohn, D.C., B. Jung, P.G. Blake, and R. Mehta. 1999. Attitudes of Canadian nephrologists towards dialysis modality selection. Peritoneal Dialysis International 19: 263-268.

BORRIE, M.J.

Borrie, M.J. 1998. An Introduction to Urinary Incontinence - Part I of V. Geriatr Aging 1 (1): 22-23.

Borrie, M.J. 1998. Long-term Consequences of Stroke. Physical Medicine and Rehabilitation State of the Art Reviews 12 (3): 459-472.

Hunskaar, S., T. Ostbye, and M.J. Borrie. 1998. The Prevalence of Urinary Incontinence in Elderly Canadians and its Association with Dementia, Ambulatory Function and Institutionalization. Norwegian Journal of Epidemiology 8 (2): 177-182.

BORRON, P.

Borron, P., E.C. Crouch, J.F. Lewis, J.R. Wright, F. Possmayer, and L.J. Fraher. 1998. Recombinant rat surfactant-associated protein D inhibits human T-lymphocyte proliferation and IL-2 production. Journal of Immunology 161 (9): 4599-4603.

Borron, P., F.X. McCormack, B.M. Elhalwagi, Z.C. Chroneos, J.F. Lewis, S. Zhu, J.R. Wright, V.L. Shepard, F. Possmayer, K. Incley, and L.J. Fraher. 1998. Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDA receptor. American Journal of Physiology 275: L679-L686.

BOUGHNER, D.R.

Boughner, D.R., J. Dunmore-Buyze, D. Heenatigala, T. Lohmann, and C. Ellis. 1999. Vascularization of bioprosthetic valve material: Progress in biomedical optics. Proceedings of Systems and Technologies for Clinical Diagnostics and Drug Discovery. San Jose, CA: January 1999. 281-287.

Christov, A.L.L., S. Lowe, C. Icton, J. Dunmore-Buyze, D.R. Boughner, E. Dai, and A.R. Lucas. 1999. Laser-induced fluorescence (LIF)-recognition of the structural composition of porcine heart valves. Photochemistry and Photobiology 69: 382-389.

BRANEY, M.

Lee, J.K., R. Yee, M. Braney, G. Stoop, M. Begemann, C. Dunne, G.J. Klein, A.D. Krahn, and N.M. VanHemel. 1999. Acute testing of the rate-smoothed pacing algorithm for ventricular rate stabilization. PACE 22: 554-561.

BRIEN, W.F.

Larocque, B.J., W.F. Brien, and K. Gilbert. 1999. The utility and prediction of allogeneic blood transfusion use in orthopedic surgery. Transfusion Medicine Reviews 13 (2): 124-131.

BRYMER, C.D.

Molnar, F.J., M. Hing, P. St. John, C.D. Brymer, K. Rockwood, and V. Hachinski. 1998. Subcortical Vascular Dementia: Survey of Treatment Patterns and Research Considerations. Canadian Journal of Neurological Science 25: 320-324.

Wells, J.L., M. Mian, and C.D. Brymer. 1998. Internal Medicine Residents' Gender Differences in Subspecialty Choice and Interest in Geriatric Medicine. Annals of the Royal College of Physicians and Surgeons of Canada 31: 385-389.

CARRUTHERS, S.G.

Campbell, N.R., M.J. Ashley, S.G. Carruthers, Y. Lacourciere, and D.W. McKay. 1999. Lifestyle modifications to prevent and control hypertension 3. Recommendations on alcohol consumption. Canadian Medical Association Journal 160 (9 Suppl): S13-20.

Carruthers, S.G. 1998. Diuretics are more efficacious than B-blockers as first-line therapy for elderly patients with hypertension. ACP Journal Club 129: 60.

Carruthers, S.G. 1998. Non Pharmacological Treatment of Hypertension; Women and Hypertension; End Organ Protection; Canadian Hypertension Studies Studies Update; AT 1 Receptor Blocker Update. Journal Club-Hypertension 1: 2.

Carruthers, S.G. 1998. Response to "Ask the Experts" on imidazoline receptor antagonists entitled Is this the future of hypertension treatment? The Canadian Journal of Diagnosis 15: 26.

Carruthers, S.G. 1998. Video Journal in Cardiology, Edition 8: Meetings update: Hypertension Optimal Treatment (HOT). Canadian Cardiovascular Society. Videotape.

Carruthers, S.G., and J. McSherry. 1998. Hypertension Optimal Treatment Study (Review). Medical Post 30.

CHIN-YEE, I.H.

Eichelbronner, O., A. Sielenkamper, M. d'Almeida, C.G. Ellis, W.J. Sibbald, and I.H. Chin-Yee. 1999. Effects of FIO2 on hemodynamic responses and O2-transport during RSR13-induced in P50. American Journal of Physiology 46: H290-H298.

Elsayed, S., R. Lannigan, and I.H. Chin-Yee. 1999. Scedosporium prolificans fungemia. Canadian Journal of Infectious Diseases 10 (1): 75-76.

Keeney, M., J.W. Gratama, I.H. Chin-Yee, and D.R. Sutherland. 1998. Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry: Time to let go! Perspectives in Cytometry 34: 280-283.

Kovacs, M.J., M.K. Cruickshank, P.S. Wells, H. Kim, I.H. Chin-Yee, B. Morrow, E. Boyle, and J. Kovacs. 1998. Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease. Haemostasis 28 (2): 62-69.

CHORAZYCZEWSKI, J.

Gros, R., C.M. Tan, J. Chorazyczewski, D.J. Kelvin, J.L. Benovic, and R.D. Feldman. 1999. G-protein-coupled receptor kinase in hypertension. Clinical Pharmacology and Therapeutics 65: 545-561.

Tan, C.M., C.G. MacDonald, J. Chorazyczewski, A.F. Burry, and R.D. Feldman. 1999. Vanadate stimulation of adenylyl cyclase: an index of tyrosine kinase vascular effects. Clinical Pharmacology and Therapeutics 66: 275-281.

CHOW, L.H.

Chow, L.H. 1998. Development of graft vascular disease in transplanted aortic segments in mice. Organ Transplantation in Rats and Mice: Microsurgical Techniques and Immunological Principles. Berlin: Springer-Verlag. 629-635.

Jiang, J., Z. Zhang, L.H. Chow, and R. Zhong. 1998. A microsurgical technique for orthotopic aorta transplantation in mice. Organ Transplantation in Rats and Mice: Microsurgical Techniques and Immunological. Berlin: Springer-Verlag. 161-165.

CLARK, W.F.

Clark, W.F. 1999. Update of plasma exchange in myeloma kidney study. CAG Bulletin (June): 8-9.

Clark, W.F., and A.M. Jevnikar. 1999. Renal transplantation for end-stage renal disease caused by systemic lupus erythematosus nephritis. Seminars in Nephrology 19: 77-85.

Clark, W.F., and L.M. Moist. 1998. Management of chronic renal insufficiency in lupus nephritis: Role of proteinuria, hypertension and dyslipidemia in the progression of renal disease. Lupus 7: 649-653.

Moist, L.M., G. Nesrallah, C. Kortas, E. Espirtu, T. Ostbye, and W.F. Clark. 1999. Plasma exchange in rapidly progressive renal failure due to multiple myeloma: A retrospective case series. American Journal of Nephrology 19: 45-50.

CORDY, P.

Spence J.D., P. Cordy, C. Kortas, and D.J. Freeman. 1999. Effect of Usual Doses of Folate Supplementation on Elevated Plasma Homocyst(e)ine in Hemodialysis Patients: No Difference between 1 and 5 mg Daily. American Journal of Nephrology 19: 405-410.

CRUICKSHANK, M.K.

Cruickshank, M.K. 1998. Commentary on "Review": Heparin and mechanical devices reduce deep venous thrombosis in elderly patients having surgery for hip fracture. Evidence Based Medicine 3 (5): 146.

Johnston, M., M. Brigden, The Thrombosis Interest Group of Canada, and M.K. Cruickshank. 1998. A cross-Canada survey of prothrombin time testing: Does the establishment of local ISI values improve the accuracy of international normalized ratio reporting? American Journal of Clinical Pathology 110: 683-690.

McLaughlin, K., A. Kadri, M.K. Cruickshank, D.J. Hollomby, A.M. Jevnikar, and N. Muirhead. 1999. Idiopathic Thrombocytopenia following CMV Infection in a Renal Transplant Recipient. American Journal of Kidney Diseases 33: E6.

DANTER, W.R.

Ferguson, K.A., A.K. Nagpal, S.D. Kirby, T. Frankovic, C.F.P. George, R.R.F. Ruby, and W.R. Danter. 1998. Evaluation of an artificial neural network in the prediction of obstructive sleep apnea from clinical criteria. Clinical and Investigative Medicine S21: 502.

DOIG, G.

Edmonds, M.W., H. Lutfiyya, S. Osborn, M. Bauer, J.L. Mahon, G. Doig, S. Kennedy, M. Glenn, and G. Molenkamp. 1999. A randomized controlled pilot study of the effects on blood glucose control of maintaining a website summary of electronically down loaded blood glucose data from a DEX glucose meter, and other home monitoring information entered with the Vista 350 Telephone, in patients with Gestational Diabetes Mellitus (GDM). Putting Health Research to Work, HEALNet Annual Conference. Calgary, AB: March 1999.

DREYER, J.

Donovan, K.D., R.V. Gerace, and J. Dreyer. 1999. Acebutalo Induced Ventricular Tachycardia Reversed with Sodium Bicarbonate. Clinical Toxicology 37 (4): 481-484.

DUPRE, J.

Dupre, J. 1999. Immunopathology of Type 1 Diabetes Mellitus: Introduction and Comments. Canadian Journal of Diabetes Care 23 (1): 22.

Dupre, J., and The Diabetes Control and Complications Trial Research Group. 1998. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the DCCT. Diabetologia 41: 416-423.

Dupre, J., and The Diabetes Control and Complications Trial Research Group. 1998. The effect of intensive treatment on residual beta-cell function in patients with Type 1 diabetes in the Diabetes Control and Complications Trials (DCCT). Annals of Internal Medicine 128: 517-523.

Dupre, J., and The Diabetes Control and Complications Trial Research Group. 1998. The incidence and prognostic significance of "early" worsening of retinopathy with intensive versus conventional treatment in the DCCT. Archives of Ophthalmology 116: 874-886.

Dupre, J., and The (EDIC) Research Group. 1999. Epidemiology of Diabetes Interventions and Complications (EDIC): Design and implementation of a long-term followup of the Diabetes Control and Complications Trial cohort. Diabetes Care 22: 99-111.

EDMONDS, M.W.

Gupta, A.K., N.K. Konnikov, P. MacDonald, P. Rich, N.W. Rodger, M.W. Edmonds, R. McManus, and R.D. Summerbell. 1998. Prevalence and epidemiology of onychomycosis of the toes in diabetics: a multicentre survey. British Journal of Dermatology 139: 665-671.

FEAGAN, B.G.

Feagan, B.G. 1998. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease. European Journal of Surgery 164 (12): 903-909.

Feagan, B.G. 1998. Research and Clinical Forums Consolidating the Advances in IBD. Budesonide Therapy for Maintenance of Remission. Wells Medical Holdings Ltd.

Feagan, B.G. 1999. Review: Corticosteroid therapy does not reduce the rate of relapse in Crohn's disease. ACP Journal Club 130: 36.

Hunt, R.H., C.A. Fallone, A.B.R. Thomson, D. Armstrong, A. Badley, A. Barkun, B.G. Feagan, et al. 1999. Update to the Canadian Consensus Conference on Helicobacter Pylori Infections in Adults. Canadian Journal of Gastroenterology 13 (3): 213-217.

Sandborn, W.J., W.J. Tremaine, D.C. Wolf, S.R. Targan, C.A. Sninsky, L.R. Sutherland, S.B. Hanauer, J.W.D. McDonald, B.G. Feagan, et al. 1999. Lack of effect of intravenous administration on time respond to azathioprine for steroid treated Crohn's disease. Gastroenteroogy 117: 527-535.

FELDMAN, R.D.

Cleroux, J., R.D. Feldman, and R.J. Petrella. 1999. Lifestyle modification to prevent and control hypertension: 4 Recommendations on physical exercise training. Canadian Medical Association Journal 160: S21-S28.

Feldman, R.D., and N.D. Schmidt. 1999. Moderate dietary salt restriction increases vascular and systemic insulin resistance. American Journal of Hypertension 12: 643-647.

Gros, R., C.M. Tan, J. Chorazyczewski, D.J. Kelvin, J.L. Benovic, and R.D. Feldman. 1999. G-protein-coupled receptor kinase in hypertension. Clinical Pharmacology and Therapeutics 65: 545-561.

Khandaker, M.H., G. Mitchell, R. Rahimpour, L. Xu, J.D. Andrews, R. Singh, H. Leung, J. Madrenas, S.S.G. Ferguson, R.D. Feldman, and D.J. Kelvin. 1999. Metalloproteinases are Involved in LPS and TNF-x Mediated Regulation of CXCR1 and CXCR2 Chemokine Receptor Expression. Blood 93: 2173-2185.

Khandaker, M.H., L. Xu, R. Rahimpour, G. Mitchell, M.E. DeVries, J.G. Pickering, S.K. Singhal, R.D. Feldman, and D.J. Kelvin. 1998. CXCR1 and CXCR2 are rapidly downmodulated by bacterial endotoxin through a unique agonist independent, tyrosine kinase dependent mechanism. Journal of Immunology 161: 1930-1938.

Mitchell, G.B., R. Rahimpour, M.H. Khandaker, L. Xu, A.I. Lazarovits, J.G. Pickering, H. Suria, J. Madrenas, D.K. Pomerntz, R.D. Feldman, and D.J. Kelvin. 1999. CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes. European Journal of Immunology 29: 1467-1476.

Rahimpour, R., G. Mitchell, M.H. Khandaker, C. Kong, B. Singh, L. Xu, A. Ochi, R.D. Feldman, S.F. Dixon, B.M. Gill, and D.J. Kelvin. 1999. Bacterial superantigens induce down-modulation of CC chemokine responsiveness in human monocytes via an alternative chemokine ligand-independent mechanism. Journal of Immunology 162: 2299-2307.

FENG, Q.-P.

Lambert, M.L., I.D. Callow, Q.-P. Feng, and J.M.O. Arnold. 1999. The effects of age on human venous responsiveness in neuropeptide Y. British Journal of Clinical Pharmacology 47: 83-89.

FERGUSON, K.A.

Pae, E.K., and K.A. Ferguson. 1999. Cephalometric characteristics of non-obese patients with OSA. Angle Orthodontist 69: 451-455.

FINNIE, K.J.C.

Finnie, K.J.C., and L.J. Melendez. 1999. Acute injury, but why? Canadian Journal of Diagnosis 17: 79-80.

Finnie, K.J.C., and L.J. Melendez. 1998. Athlete's heart. Canadian Journal of Diagnosis 16: 37-38.

Finnie, K.J.C., and L.J. Melendez. 1999. A clue to the crime. Canadian Journal of Diagnosis 17: 68-73.

Finnie, K.J.C., and L.J. Melendez. 1999. The clue to the crime. Canadian Journal of Diagnosis 16: 68-73.

Finnie, K.J.C., and L.J. Melendez. 1998. From massage to message. Canadian Journal of Diagnosis 16: 55-56.

Finnie, K.J.C., and L.J. Melendez. 1998. On reflection. Canadian Journal of Diagnosis 15: 47-48.

Finnie, K.J.C., and L.J. Melendez. 1999. Pacing for pauses. Canadian Journal of Diagnosis 17: 61-62.

Finnie, K.J.C., and L.J. Melendez. 1998. The path less travelled. Canadian Journal of Diagnosis 16: 55-57.

Melendez, L.J., and K.J.C. Finnie. 1998. And then there were none. Canadian Journal of Diagnosis 16: 55-56.

Melendez, L.J., and K.J.C. Finnie. 1999. Oh, sweet chocolates! Canadian Journal of Diagnosis 17: 59-60.

Melendez, L.J., and K.J.C. Finnie. 1999. Pas de quatre. Canadian Journal of Diagnosis 17: 75-76.

Melendez, L.J., and K.J.C. Finnie. 1998. Pericardial confusion. Canadian Journal of Diagnosis 16: 37-38.

Melendez, L.J., and K.J.C. Finnie. 1999. Postoperative ECG. Canadian Journal of Diagnosis 17: 57-59.

FRAHER, L.J.

Fraher, L.J., R. Avram, P.H. Watson, G.N. Hendy, J.E. Henderson, K.L. Chong, D. Goltzman, P. Morley, G.E. Willick, J.F. Whitfield, and A.B. Hodsman. 1999. A comparison of the biochemical responses to parathyroid hormone (hPTH)-1-31 NH2 and hPTH-(1-34) in healthy humans. Journal of Clinical Endocrinology and Metabolism 84: 2739-2743.

Hodsman, A.B., P.H. Watson, D. Drost, L.J. Fraher, J. Hock, and H. Bryant. 1999. The addition of a raloxifene analogue (LY117018) allows for reduced PTH (1-34) dosing during reversal of osteopenia in ovariectomized rats. Journal of Bone and Mineral Research 14: 675-679.

Hodsman, A.B., P.H. Watson, D. Drost, L.J. Fraher, D. Holdworth, M. Thornton, J. Hock, and H. Bryant. 1999. Assessment of maintenance therapy with reduced doses of PTH (1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat. Bone 24: 451-455.

Watson, C.S., S.E. White, J.H. Homan, K.A. Kimura, J.F. Brien, L.J. Fraher, and J.R.G. Challis. 1999. Increased cerbral extracellular adenoisine and decreased protaglandin E2 during ethanol-induced inhibition of ovine fetal breathing movements. Journal of Applied Physiology 86: 1410-1420.

Watson, P.H., L.J. Fraher, M. Kisiel, D. DeSousa, G. Hendy, and A.B. Hodsman. 1999. Enhanced osteoblast development after continuous infusion of hPTH (1-84) in the rat. Bone 24: 89-94.

FREEMAN, D.J.

Spence, J.D., P.A. Barnett, R.A. Hegele, A.J. Marian, D.J. Freeman, and M.R. Malinow. 1999. Plasma Homocyst(e)ine level predicts carotid plaque better than Methylenetetrahydrofolate reductase (MTHFR) geneotype. Stroke 30 (5): 969-973.

Spence, J.D., M.R. Malinow, P.A. Barnett, A.J. Marian, D.J. Freeman, and R.A. Hegele. 1999. Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke 30: 969-973.

Tschen, A.C., M.J. Rieder, K. Oyewumi, and D.J. Freeman. 1999. The Cytotoxicity of Clozapine Metabolites: Implications for Predicting Clozapine-induced Agranulocytosis. Clinical Pharmacology & Therapeutics 65 (5): 526-532.

GEORGE, C.F.P.

George, C.F.P. 1999. Diagnostic techniques in obstructive sleep apnea. Progress In Cardiovascular Diseases 4: 355-366.

George, C.F.P. 1998. Medico-legal aspects of driving with a sleep disorder. Ontario Thoracic Reviews 10 (Fall): 4-6.

George, C.F.P., and A. Smiley. 1999. Sleep apnea and automobile accidents. Sleep 22: 790-795.

Kryger, M.H., and C.F.P. George. 1998. Differential diagnosis and evaluation of sleepiness. Pulmonary Diseases and Disorders, Vol. 103. 3rd ed. A.P. Fishman. Philadelphia: McGraw-Hill. 1639-1646.

GERACE, R.V.

Donovan, K.D., R.V. Gerace, and J. Dreyer. 1999. Acebutalo Induced Ventricular Tachycardia Reversed with Sodium Bicarbonate. Clinical Toxicology 37 (4): 481-484.

GHENT, C.N.

Ghent, C.N. 1999. Stomal Varices. British Medical Journal 318: 1708.

Kumar, N., W.J. Wall, D. Grant, M. Bloch, C.N. Ghent, P.C. Adams, and P.J. Marotta. 1999. Liver retransplantation. Transplantation Proceedings 31: 541-542.

Kutt, J., S. Asfar, C.N. Ghent, and D. Grant. 1999. Small bowel transplantation. Anaesthesia and Transplantation. M.D. Sharpe, and A.W. Gelb. Boston, MS: Butterworth-Heinmann. 201-216.

St. Amand, M., M. Al Sofayan, C.N. Ghent, and W. Wall. 1999. Liver transplantation. Anaesthesia and Transplantation. M.D. Sharpe, and A.W. Gelb. Boston, MS: Butterworth-Heinmann. 171-200.

GILBERT, K.

Larocque, B.J., W.F. Brien, and K. Gilbert. 1999. The utility and prediction of allogeneic blood transfusion use in orthopedic surgery. Transfusion Medicine Reviews 13 (2): 124-131.

GUENTHER, L.C.

Dolynchuck, K., P. Hull, L.C. Guenther, R.G. Sibbald, A. Brassard, M. Cooling, L. Delorme, W. Gulliver, D. Hamelin Bourassa, V. Ho, B. Kunimoto, T. Overholt, K. Papp, and J. Tousignant. 1999. The role of Apligraf in the treatment of venous leg ulcers. Ostomy/Wound Management 45 (1): 34-43.

Gooderham, M., and L.C. Guenther. 1999. Impact of a sun awareness curriculum on medical students' knowledge, attitudes and behaviour. Journal of Cutaneous Medicine and Surgery 3 (4): 182-187.

Gooderham, M., and L.C. Guenther. 1999. Sun and the Skin: Evaluation of a sun awareness program for elementary school students. Journal of Cutaneous Medicine and Surgery 3 (5): 230-235.

Guenther, L.C. 1999. Advances in molecular biology. Dermatology Times 8 (6): 2.

Guenther, L.C. 1999. Combination treatment for psoriasis. Dermatology Times 8 (1): 2.

Guenther, L.C. 1998. Encouraging new therapies for HPV. Dermatology Times 7 (8): 2.

Guenther, L.C. 1999. An FRCP(C) forever? Dermatology Times 8 (3): 2.

Guenther, L.C. 1999. Head Lice becoming a worldwide problem. Dermatology Times 8 (2): 2.

Guenther, L.C. 1998. Promising treatments for atopic dermatitis. Dermatology Times 7 (7): 2.

Guenther, L.C. 1999. Sun awareness initiatives. Dermatology Times 8 (4): 2.

Guenther, L.C. 1999. Tazarotene: A receptor-selective topical retinoid, in the treatment of psoriasis. Today's Therapeutic Trends 17 (2): 133-145.

Guenther, L.C. 1999. Wound healing. Dermatology Times 8 (5): 2.

Shum, D.T., L.C. Guenther, J. Rasmussen, A. Utovac, and K. Alanen. 1999. An Atlas of Histopathology of Skin Diseases. New York: Parthenon.

HARTH, M.

Harth, M. 1998. Fibromyalgia, litigation and the medical expert witness More heat than light. Pain Research Management 3: 77-80.

White, K.P., M. Harth, M. Speechley, and T. Ostbye. 1999. Testing an instrument to screen for fibromyalgia syndrome in general population studies: The London Fibromyalgia Epidemiology Study Screening Questionnaire. Journal of Rheumatology 26: 880-884.

White, K.P., W.R. Nielson, and M. Harth. 1999. Psychological distress and healthcare Seeking behaviour: Caution warranted in interpreting data. Journal of Rheumatology 26: 244-246.

White, K.P., M. Speechley, M. Harth, et al. 1999. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario. Arthritis & Rheumatism 42 (1): 76-83.

White, K.P., M. Speechley, M. Harth, and T. Ostbye. 1999. The London Fibromyalgia Epidemiology Study: Direct health care costs of fibromyalgia syndrome in London, Canada. Journal of Rheumatology 26: 885-889.

HEGELE, R.A.

Anand, S.S., S. Yusuf, V. Vuksan, S. Devanesen, P. Montague, L. Kelemen, J. Bosch, C. Sigouin, K.K. Teo, E. Lonn, H.C. Gerstein, R.A. Hegele, and M. McQueen. 1998. The study of health assessment and risk in ethnic groups (SHARE): rationale and design. Canadian Journal of Cardiology 14: 1349-1357.

Busch, C.P., S.B. Harris, A.J.G. Hanley, B. Zinman, and R.A. Hegele. 1999. The ADD1 G460W polymorphism is not associated with variation in blood pressure in Canadian Oji-Cree. Journal of Human Genetics 44: 225-229.

Busch, C.P., D.D. Ramdath, S. Ramsewak, and R.A. Hegele. 1999. Association of PON2 variation with birth weight in Trinidadian neonates of South Asian ancestry. Pharmacogenetics 9: 351-356.

Connelly, P.W., and R.A. Hegele. 1998. Hepatic lipase deficiency. Critical Reviews In Clinical Laboratory Sciences 35: 547-572.

Connelly, P.W., and R.A. Hegele. 1999. Hepatic lipase deficiency (Chapter 48). Lipoproteins in Health and Disease. D.J. Betteridge, D.R. Illingworth, and J. Shepherd. New York: Oxford University Press.

Connelly, P.W., M. Poapst, J. Davignon, S. Lussier-Cacan, B. Reeder, R. Lessard, R.A. Hegele, Csima A., and The Canadian Heart Health Surveys Research Group. 1999. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the population of two Canadian provinces: Quebec and Saskatchewan. Canadian Journal of Cardiology 15: 409-418.

Hegele, R.A. 1999. Genetic prediction of coronary heart disease: Lessons from Canada. Scandinavian Journal of Clinical and Laboratory Investigation 230: 153-167.

Hegele, R.A. 1999. Genetics in childhood atherosclerosis. Progress in Pediatric Cardiology 9: 213-224.

Hegele, R.A. 1999. Lessons from genetic studies in native Canadian Populations. Nutrition Reviews 57: 43-50.

Hegele, R.A. 1999. Paraoxonase genes and disease. Annals of Medicine 31: 217-225.

Hegele, R.A. 1998. A review of intestinal fatty acid binding protein gene variation and the plasma lipoprotein response to dietary components. Clinical Biochemistry 31: 609-612.

Hegele, R.A., C.P. Busch, T.K. Young, P.W. Connelly, and H. Cao. 1999. Mannose-binding lectin gene variation and cardiovascular disease in Canadian Inuit. Clinical Chemistry 45: 1283-1285.

Hegele, R.A., H. Cao, S.B. Harris, A.J.G. Hanley, and B. Zinman. 1999. The hepatic nuclear factor-1a G319S variant is associated with early onset type 2 diabetes in Canadian Oji-Cree. Journal of Clinical Endocrinology and Metabolism 84: 1077-1082.

Hegele, R.A., H. Cao, S.B. Harris, A.J.G. Hanley, and B. Zinman. 1999. HNF-1a G31S: a private mutation in Oji-Cree associated with type 2 diabetes. Diabetes Care 22: 524.

Hegele, R.A., S.B. Haris, A.J.G. Hanley, H. Cao, and B. Zinman. 1998. G-protein B3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hypertension 32: 688-692.

Hegele, R.A., S.B. Harris, P.W. Connelly, A.J.G. Hanley, L.-C. Tsui, B. Zinman, and S.W. Scherer. 1998. Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree. Clinical Genetics 54: 394-399.

Hegele, R.A., S.B. Harris, A.J.G. Hanley, and B. Zinman. 1999. Association between AGT codon 235 polymorphism and variation in serum concentrations of creatinine in Canadian Oji-Cree. Clinical Genetics 55: 438-443.

Hegele, R.A., S.B. Harris, A.J.G. Hanley, and B. Zinman. 1999. Association between AGT T235 variant and microalbuminuria in Canadian Oji-Cree with type 2 diabetes mellitus. Clinical Biochemistry 32: 201-205.

Hegele, R.A., S.B. Harris, B. Zinman, A.J.G. Hanley, and P.W. Connelly. 1999. Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetes. Clinical Biochemistry 32: 143-148.

Hegele, R.A., S.B. Harris, B. Zinman, J. Wang, H. Cao, A.J.G. Hanley, L.-C. Tsui, and S.W. Scherer. 1998. Variation in the AU(AT)-rich element within the 3'-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians. Journal of Clinical Endocrinology and Metabolism 83: 3980-3983.

Hegele, R.A., J.A. Little, and P.W. Connelly. 1999. Atorvastatin in the management of an index patient with complete hepatic lipase deficiency. Atherosclerosis 143: 219-222.

Hegele, R.A., F. Sun, S.B. Harris, C. Anderson, A.J.G. Hanley, and B. Zinman. 1999. Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers. Journal of Human Genetics 44: 10-14.

Spence, J.D., P.A. Barnett, D.E. Bulman, and R.A. Hegele. 1999. A proposed strategy to ascertain probands with a non-traditional atherosclerosis risk factor. Atherosclerosis 144: 429-434.

Wang, J., D.W. Killinger, and R.A. Hegele. 1999. A novel 4 base pair deletion with DAX-1 in a Canadian patient with X-linked congenital adrenal hypoplasia and hypogonadotrophic hypogonadism. Journal of Investigative Medicine 47: 232-235.

Whitman, S.C., S.L. Hazen, D.B. Miller, R.A. Hegele, J.W. Heinecke, and M.W. Huff. 1999. Modification of type III VLDL, their remnants and VLDL from apo-E-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages. Arteriosclerosis, Thombosis and Vascular Biology 19: 1238-1249.

Whitman, S.C., C.G. Sawyez, D.B. Miller, R.A. Hegele, and M.W. Huff. 1999. Uptake of Type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-y. Journal of Lipid Research 40: 1017-1028.

HILL, D.J.

Bidey, S.P., D.J. Hill, and M.C. Eggo. 1999. Growth factors and goitrogenesis. Journal of Endocrinology 160: 321-332.

de los Rios, P., and D.J. Hill. 1999. Cellular localization and expression of insulin-like growth factors (IGFs) and IGF binding proteins within the epiphyseal growth plate of the ovine fetus: possible functional implications. Canadian Journal of Physiology and Pharmacology 77: 235-249.

Hill, D.J. 1999. Fetal programming of the pancreatic beta cells and the implications for postnatal diabetes. Seminars in Neonatology 4: 99-113.

Hill, D.J. 1999. Models for understanding early human development. Seminars in Neonatology 4: 75-78.

Hill, D.J. 1999. Pancreatic beta cell growth, development and regeneration. Canadian Journal of Diabetes Care 23: 22-31.

Ilieva, A., S. Yuan, R.N. Wang, D. Agapitos, D.J. Hill, and L. Rosenberg. 1999. Pancreatic islet cell survival following islet isolation - The role of cellular interactions in the pancreas. Journal of Endocrinology 161: 357-364.

Walter, H.J., M. Berry, D.J. Hill, S. Cwyfan-Hughes, J. Holly, and A. Logan. 1999. Distinct sites of insulin-like growth factor (IGF)-II expression and localisation in lesioned rat brain: Possible roles of IGF binding proteins in mediating IGF-II action. Endocrinology 140: 5209-532.

HODSMAN, A.B.

Watson, P.H., L.J. Fraher, M. Kisiel, D. DeSousa, G. Hendy, and A.B. Hodsman. 1999. Enhanced osteoblast development after continuous infusion of hPTH (1-84) in the rat. Bone 24: 89-94.

HOLLOMBY, D.J.

HOPKINS, M.

Grace, G.M., W.R. Nielson, M. Hopkins, and M. Berg. 1999. Concentration and memory deficits in patients with fibromyalgia syndrome. Journal of Clinical and Experimental Neuropsychology 21: 477-487.

HORGAN-BELL, C.

Gupta, A.K., C. Horgan-Bell, and R. Summerbell. 1998. Onychomycosis Associated with Onychocola Canadensis: Ten Case Reports and a review of the literature. Journal of the American Academy of Dermatology 39: 410-417.

HOUSE, A.A.

House, A.A., and J.G. Donnely. 1999. Effect of multivatimins (Nephro-Vite Rx) on plasma homocysteine and folate levels in hemodialysis patients. ASAIO Journal 45 (1): 94-97.

House, A.A., B. Pham, and D.E. Page. 1998. Transfusion and recombinant human erythropoetin (rhEPO) requirements differ between dialysis modalities. Nephrology Dialysis Transplantation 13 (7): 1763-1769.

Ooi, D.S., and A.A. House. 1998. Troponin T in hemodialyzed patients using Elecsys TnT STAT immunoassay. Clinical Chemistry 44 (7): 1410-1416.

Page, D.E., and A.A. House. 1998. Important cost difference of blood transfusions and erythropoietin between hemodialysis and peritoneal dialysis patients. Advances in Peritoneal Dialysis 14: 87-89.

HUFF, M.W.

Burnett, J.R., P.H.R. Barrett, P. Vicini, D.B. Miller, D.E. Telford, S.J. Kleinstiver, and M.W. Huff. 1998. The HMG-CoA reductase inhibitor, atorvastatin, enhances the fractional clearance rate of postprandial triglyceride-rich lipoproteins. Arteriosclerosis, Thrombosis and Vascular Biology 18: 1906-1914.

Burnett, J.R., L.J. Wilcox, and M.W. Huff. 1999. The role of ACAT in the regulation of hepatic apo beta secretion. Clinica Chimica Acta 268: 231-242.

Burnett, J.R., L.J. Wilcox, D.E. Telford, S.J. Kleinstiver, P.H.R. Barrett, R.S. Newton, and M.W. Huff. 1999. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Journal of Lipid Research 40: 1317-1327.

Wilcox, L.J., P.H.R. Barrett, and M.W. Huff. 1999. Differential regulation of apo-beta secretion from HepG2 cells by two HMG-CoA reductase inhibitors: atorvastatin and simvastatin. Journal of Lipid Research 40: 1078-1089.

Wilcox, L.J., P.H.R. Barrett, R.S. Newton, and M.W. Huff. 1999. Apo-beta-100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011; an effect associated with enhanced intracellular degradation of apo-beta. Arteriosclerosis, Thrombosis and Vascular Biology 19: 939-949.

JEVNIKAR, A.M.

Cagiannos, C., R. Zhong, Z. Zang, J. Jiang, B.M. Garcia, S. Chakrabarti, A.M. Jevnikar, N.R. Sinclair, and D.R. Grant. 1998. Effect of major histocompatibility complex expression on murine intestinal graft survival. Transplantation 66 (10): 1369-1374.

Clark, W.F., and A.M. Jevnikar. 1999. Renal transplantation for end-stage renal disease caused by systemic lupus erythematosus nephritis. Seminars in Nephrology 19: 77-85.

Lazarovits, A.I., L. Visser, S. Asfar, C.E. LeFeuvre-Haddad, T. Zhong, D.J. Kelvin, C. Kong, M.H. Khandaker, B. Singh, M. White, A.M. Jevnikar, Z. Zhang, and S. Poppema. 1999. Mechanisms of induction of renal allograft tolerance in CD45RB-treated mice. Kidney International 55: 1303-1310.

Liu, J., L.E. Purdy, S. Rabinovitch, A.M. Jevnikar, and J.F. Elliott. 1999. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA null NOD mice. Diabetes 48: 469-477.

Ma, S., and A.M. Jevnikar. 1999. Autoantigens produced in plants for oral tolerance therapy of autoimmune diseases. Advances In Experimental Medicine and Biology 464: 179-194.

McLaughlin, K., B. Gholoum, C. Guiraudon, A.M. Jevnikar, and N. Muirhead. 1998. Rapid development of drug-induced lupus nephritis in the absence of extra-renal disease in a patient receiving procainamide. American Journal of Kidney Diseases 32 (4): 698-702.

Noorchashm, H., Y.K. Lieu, N. Noorchashm, S.Y. Rostami, S.A. Greeley, A. Schlachterman, H.K. Song, L.E. Noto, A.M. Jevnikar, C.F. Barker, and A. Naji. 1999. 1-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. Journal of Immunology 163 (2): 743-750.

Singh, B., S. Prange, and A.M. Jevnikar. 1998. Protective and Destructive Effects of Microbial Infection in Insulin-Dependent Diabetes Mellitus. Seminars In Immunology 10 (1): 79-86.

Wuthrich, R.P., A.M. Jevnikar, and V. Rubin Kelly. 1999. Understanding Lupus Nephritis: Unraveling the Pathogenesis Through Molecular Approaches in Murine Models (Chapter 4). Lupus Nephritis. E.J. Lewis, M.M. Schwartz, and S.M. Korbets. Oxford: Oxford Clinical Nephrology Series. 103-125.

KILLINGER, D.W.

KIRBY, A.S.

Hebert, P.C., G. Wells, M.A. Blajchman, J. Marshall, C.M. Martin, G. Pagliarello, M. Tweeddale, I. Schweitzer, E. Yetisir, and A.S. Kirby. 1999. Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care. The New England Journal of Medicine 340 (6): 409-417.

KLEIN, G.J.

Krahn, A.D., G.J. Klein, R. Yee, and V. Manda. 1999. The high cost of syncope: Cost implications of a new insertable loop recorder in the investigation of recurrent syncope. American Heart Journal 137: 870-877.

Krahn, A.D., G.J. Klein, R. Yee, T. Takle-Newhouse, and C. Norris. 1999. Utility of an extended monitoring strategy in patients with problematic syncope. Circulation 99: 406-410.

Krahn, A.D., R. Yee, G.J. Klein, and A.C. Skanes. 1999. Syncope: Experience with the implantable loop recorder. American College of Cardiology Current Journal Review 8: 80-84.

Murgatroyd, F.D., and G.J. Klein. 1999. AVNRT: What goes around, comes around - but where? PACE 22: 259-262.

Sharpe, M.D., D.J. Cuillerier, J.K. Lee, M. Basta, A.D. Krahn, G.J. Klein, and R. Yee. 1999. Sevoflurane has no effect on sinoatrial node function or on normal atrio-ventricular and accessory pathway conduction in Woff-Parkinson-White Syndrom during alfentanil/midazolam anesthesia. Anesthesiology 90: 60-65.

Simpson, C.S., A.D. Krahn, G.J. Klein, R. Yee, A.C. Skanes, V. Manda, and C. Norris. 1999. A cost effective approach to the investigation of syncope: Relative merit of different diagnostic strategies. Canadian Journal of Cardiology 15: 579-584.

KORTAS, C.

KOSTUK, W.J.

Kobashigawa, J., L. Miller, D. Renlund, R. Mentzer, E. Alderman, R. Bourge, M. Constanzo, Eisen H., The Mycopheonlate Mofetil Investigators, G. Dureau, R. Ratkovec, M. Hummel, D. Ipe, J. Johnson, A. Keogh, R. Mamelok, D. Mancini, F. Smart, H. Valantine, and W.J. Kostuk. 1998. A randomized active-controlled trial of mycophenolate mofetril in heart transplant recipients. Transplantation 66: 507-515.

Topol, E.J., The Epistent Investigators, and W.J. Kostuk. 1998. Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-11b/111a blockade. Lancet 352: 87-92.

KOVACS, M.J.

Bauld, D.L., and M.J. Kovacs. 1999. Dalteparin in Emergency patients to prevent admission prior to investigation for venous thromboembolism. American Journal of Emergency Medicine 17: 11-15.

Kearon, C., M. Gent, J. Hirsh, J. Weitz, M.J. Kovacs, D.R. Anderson, A.G. Turpie, D. Green, J.S. Ginsberg, P. Wells, J.J.A. MacKinnon, and M. Math. 1999. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine 340 (12): 901-907.

Kovacs, M.J., M. Keeney, K. MacKinnon, and E. Boyle. 1999. Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic Dalteparin or unfractionated heparin. Clinical and Laboratory Haematology 21 (March): 55-60.

Wells, P.S., M.J. Kovacs, J. Bormanis, M.A. Forgie, D. Goudie, B. Morrow, and J. Kovacs. 1998. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight Heparin. Archives of Internal Medicine 58 (16): 809-812.

KRAHN, A.D.

Barlow, M., and A.D. Krahn. 1999. The role of pacing in neurocardiogenic syncope. Cardiac Electrophysiol Rev 2: 369-372.

Kenny, R., and A.D. Krahn. 1999. The implantable loop recorder: Evaluation of unexplained syncope. Heart 81: 431-433.

Krahn, A.D., G.J. Klein, R. Yee, T. Takle-Newhouse, and C. Norris. 1999. Utility of an extended monitoring strategy in patients with problematic syncope. Circulation 99: 406-410.

Krahn, A.D., R. Yee, G.J. Klein, and A.C. Skanes. 1999. Syncope: Experience with the implantable loop recorder. American College of Cardiology Current Journal Review 8: 80-84.

LANNIGAN, R.

Elsayed, S., R. Lannigan, and I.H. Chin-Yee. 1999. Scedosporium prolificans fungemia. Canadian Journal of Infectious Diseases 10 (1): 75-76.

LAROCQUE, B.J.

Lapointe, H.J., J.E. Armstrong, and B.J. Larocque. 1998. Clinical Criteria for the use of a decision-making framework for the medically compromised patient: Hypertension and Diabetes Mellitus. Journal of the Canadian Dental Association 64: 704-709.

Larocque, B.J., W.F. Brien, and K. Gilbert. 1999. The utility and prediction of allogeneic blood transfusion use in orthopedic surgery. Transfusion Medicine Reviews 13 (2): 124-131.

LAZAROVITS, A.I.

LEASA, D.J.

Leasa, D.J. 1999. Oxford Textbook of Critical Care. Annals of the Royal College of Physicians and Surgeons of Canada 32: 5.

Rutledge, F.S., and D.J. Leasa. 1999. Acute respiratory failure. Bone's Atlas of Pulmonary and Critical Care Medicine. R.C. Bone, G.D. Campbell, D. Payne, A.C. Arroliga, R.B. George, and L.J. Goodman. Philadelphia: Williams & Willkins.

LEWIS, J.F.

Lewis, J.F., L. McCaig, D. Hafner, R. Spragg, R.A.W. Veldhuizen, and C. Kerr. 1999. Dosing and delivery assessments of a recombinant surfactant in lung injured adult sheep. American Journal of Respiratory and Critical Care Medicine 159: 741-747.

Sen, M., and J.F. Lewis. 1999. Tuberculosis: A burden in Canada. Canadian Journal of Diagnosis (March): 117-127.

Vanderzwan, J., L. McCaig, S. Mehta, M. Joseph, J. Whitsett, D.G. McCormack, and J.F. Lewis. 1998. Characterizing alterations in the pulmonary surfactant system in a rat model of pseudomonas aeruginosa pneumonia. European Respiratory Journal 12: 1388-1396.

Veldhuizen, R.A.W., L.-J. Yao, and J.F. Lewis. 1999. Examination of variables affecting surfactant aggregate conversion in vitro. Experimental Lung Research 25: 127-141.

LINDSAY, R.M.

Jindal, K., J.K. Ethier, R.M. Lindsay, E.P. Barre, J.E. Kappel, E.J.F. Carlisle, and A. Common. 1999. Clinical practice guidelines for vascular access. American Journal of Kidney Diseases 10: S297-S305.

Leypoldt, J.K., and R.M. Lindsay. 1999. Hemodynamic monitoring during hemodialysis. Advances in Renal Replacement Therapy 6: 233-242.

Lindsay, R.M. 1999. Quality of life assurance in hemodialysis (Chapter 14). Quality Assurance in Dialysis. 2nd ed. L. Henderson, and R. Thuma. Dordrecht, The Netherlands: Kluwer Academic Publishers. 143-154.

Lindsay, R.M., P.G. Blake, and E. Bradfield. 1998. The estimation of hemodialysis access blood flow rates by a urea methodology is a poor predictor of access outcome. ASAIO Journal 44: 818-822.

Lindsay, R.M., and J.K. Leypoldt. 1999. Monitoring vascular access flow. Advances in Renal Replacement Therapy 6: 273-277.

Nisenson, A., R.M. Lindsay, S. Swan, P. Seligman, and J. Strobos. 1999. Sodium Ferric Gluconate Complex in Sucrose is Safe and Effective in Hemodialysis. American Journal of Kidney Diseases 33: 471-482.

Pandaya, S., and R.M. Lindsay. 1999. The relationship between cardiac output and access flow during hemodialysis. ASAIO Journal 45: 135-138.

Yarar, D., A.K. Cheung, R.M. Lindsay, P. Sakiewicz, E. Paginini, R.R. Steuer, and J.K. Leypoldt. 1999. An Ultrafiltration Method for Measuring Vascular Access Blood Flow Rates During Routine Hemodialysis. Kidney International 56: 1129-1135.

LLOYD, D.A.

Valberg, L.S., and D.A. Lloyd. 1998. Gastrointestinal Studies v3.0: Multimedia Program for Student and Resident Education.

LUCAS, A.R.

Christov A., E. Dai, L.Y. Liu, L. Miller, P. Nash, A.S. Lalani, G. McFadden, P.N. Nation, J. Tulip, and A.R. Lucas. 1999. Detection of transplant vasculopathy in a rat aortic allograft model by fluorescence spectroscopic optical analysis. Lasers In Surgery and Medicine 24: 346-359.

Lalani, A.S., J. Masters, K. Graham, L.Y. Liu, A.R. Lucas, and G. McFadden. 1999. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Journal of Virology 256: 233-245.

MADRENAS, J.

Baroja, M.L., L.B. Cielinski, T.J. Torphy, R.L. Wange, and J. Madrenas. 1999. Specific CD3-e association of a physphodiesterase 4B isoform determines its selective tyrosine phyosphorylation after CD3 ligation. Journal of Immunology 162: 2016.

Jiang, J., H. Wang, J. Madrenas, and R. Zhong. 1999. Surgical technique for vascularized thymus transplantation in mice. Microsurgery 19: 56.

Madrenas, J. 1999. Differential signalling by variant ligands of the T cell receptor and the kinetic model of T cell activation. Life Sciences 64: 717.

Salojin, K., J. Zhang, J. Madrenas, and T.D. Delovitch. 1998. T cell anergy: biochemical basis and possible relationship to the development of autoimune disease. Immunology Today 19: 468.

MAHON, J.L.

Mahon, J.L., A. Laupacis, R.V. Hodder, D.A. McKim, N.A.M. Paterson, T.E. Wood, and A. Donner. 1999. Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. Chest 115: 38-48.

Meltzer, S.A., L. Leiter, D. Daneman, et al, The Steering and Expert Committees, and J.L. Mahon. 1998. 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Medical Association Journal (CMAJ) 159 (8 Suppl): S1-S29. J. Mahon (Member, The Steering and Expert Committee).

MAROTTA, P.J.

Graziadei, I.W., R.H. Wiesner, P.J. Marotta, et al. 1999. Recurrence of PSC following liver transplantation. Hepatology 4: 1050-1056.

Kumar, N., W.J. Wall, D. Grant, M. Bloch, C.N. Ghent, P.C. Adams, and P.J. Marotta. 1999. Liver retransplantation. Transplantation Proceedings 31: 541-542.

Marotta, P.J., and K. Madala. 1998. Approach to abnormal liver enzymes. Patient Care Canada 9: 33-36.

MARTIN, C.M.

Keenan, S.P., and C.M. Martin. 1999. Creation of a Critical Care Research Network. Current Opinions in Critical Care 4: 470-475.

Madorin, S., C.M. Martin, and W.J. Sibbald. 1999. Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis. Critical Care Medicine 27 (2): 394-400.

Martin, C.M., W.J. Sibbald, and R.C. Bone. (Editors). 1998. Management of Oxygen Delivery in the Critically Ill Patient. Bone's Atlas of Pulmonary and Critical Care Medicine. Philadelphia: Current Medicine, Inc.

MASSEL, D.

Bayliff, C., D. Massel, R. Inculet, and R. Malthaner. 1999. Evaluation of propranolol for the prevention of postoperative arrhythmias in patients undergoing noncardiac thoracic surgery. Annals of Thoracic Surgery 67: 182-186.

Massel, D. 1998. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. Results of the FRESCO trial. Annals of Internal Medicine 129: 64.

Massel, D. 1999. A contrary view on a bayesian approach to treatment efficacy. Annals of the Royal College of Physicians and Surgeons of Canada 32: 79-81.

Massel, D. 1998. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. British Medical Journal 3: 177.

Massel, D. 1998. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy (commentary). Annals of Internal Medicine 129: 63.

Massel, D. 1999. Potential cost-effectiveness of tissue plasminogen activator among patients previously treated with streptokinase. Canadian Journal of Cardiology 15: 173-179.

Massel, D. 1999. Similar, the same or just not different: A guide for deciding whether treatments are clinically equivalent. Canadian Journal of Cardiology 15: 556-562.

Renner, S.M., D. Massel, and B.C. Moon. 1999. Mediastinal irradiation: A risk factor for atherosclerosis of the internal thoracic arteries. Canadian Journal of Cardiology 15: 597-600.

MCCAIG, L.

MCCORMACK, D.G.

Scott, J.A., and D.G. McCormack. 1999. Nonadrenergic noncholinergic vasodilation of guinea pig pulmonary arteries is mediated by nitric oxide. Canadian Journal of Physiology and Pharmacology 77: 89-95.

Scott, J.A., and D.G. McCormack. 1999. Selective in vivo inhibition of inducible nitric oxide synthase in a model of sepsis. American Journal of Physiology 86: 1739-1744.

Scott, J.A., M.L. Weir, J.W. Xuan, A.F. Chambers, and D.G. McCormack. 1998. Osteopontin inhibits inducible NO synthase activity in rat vascular tissue. American Journal of Physiology 275: H2258-H2265.

MCDONALD, J.W.D.

McDonald, J.W.D. 1998. Maintenance of certification: A commitment to fairness and excellence. The CPD Newsletter (RCPSC) (Oct.).

MCDONALD, T.J.

Carroll, R.E., K.A. Matkowskyj, I. Cantave, S. Chakrabarti, T.J. McDonald, and R.V. Benya. 1999. Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans. American Journal of Physiology 276 (39): G655-G665.

Deshpande, N.A., T.J. McDonald, and M.A. Cook. 1999. Endogenous interstitial adenosine in isolated myenteric neural networks varies inversely with prevailing PO2. American Journal of Physiology 276 (39): G875-G885.

Fox-Threlkeld, J.-A.E.T., McDonald T.J., Z. Woskowska, K. Iesaki, and Daniel E.E. 1999. Pituitary adenylate cyclase-activating peptide as a neurotransmitter in the canine ileal circular muscle. Journal of Pharmacology and Experimental Therapeutics 290: 66-75.

Lawlor, E.R., J.F. Lim, W. Tao, C. Poremba, C.J. Chow, I.V. Kalousek, H. Kovar, T.J. McDonald, and P.H.B. Sorensen. 1998. The Ewing tumor family of peripheral primitive neuroectodermal tumors expresses human gastrin-releasing peptide. Cancer Research 58: 2469-2476.

McDonald, T.J. 1998. GLP-1 and Amylin: Potential Therapies for Diabetes Mellitus. Canadian Journal of Diabetes Care 22: 23-24.

MCMANUS, R.

MEHTA, S.

Baltzan, M., S. Mehta, T.H. Kirkham, and M.G. Cosio. 1999. A randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. American Journal of Respiratory and Critical Care Medicine 160: 192-197.

De Sanctis, G.T., J.A. MacLean, K. Hamada, S. Mehta, J.A. Scott, H. Grasemann, A. Jiao, L. Kobzik, W.W. Wolyniec, S. Qin, P.L. Huang, A. Fabian, C.S. Venugopal, T. Massaro, and Drazen. J.M. 1999. Contribution of nitric oxide synthase 1, 2 and 3 to airway responsiveness in a murine model of allergic asthma. Journal of Experimental Medicine 189: 1621-1629.

Mehta, S., and J.M. Drazen. 1999. Bronchodilator actions of nitric oxide and related compounds (Chapter 7). Nitric Oxide in Pulmonary Processes: Role in Physiology and Pathophysiology of Lung. M.G. Belvisi, and J. Mitchell. Basel, Switzerland: Birkhauser Verlag AG. 127-149.

Mehta, S., D. Javeshghani, P. Datta, R.D. Levy, and S. Magder. 1999. Porcine endotoxaemic shock is associated with increased expired nitric oxide. Critical Care Medicine 27: 385-393.

MELENDEZ, L.J.